A major gene for bovine ovulation rate has been mapped to a 1.2 Mb region of chromosome 10. Screening of coding regions of positional candidate genes within this region failed to reveal a causative polymorphism, leading to the hypothesis that the phenotype results from differences in candidate gene expression rather than alteration of gene structure. This study tested differences in expression of positional candidate genes in granulosa cells between carriers and noncarriers of the high fecundity allele, as well as characterizing differences in the transcriptomic profile between genotypes. Five carriers and five noncarriers, female descendants of "Trio," a carrier of the high fecundity allele were initially used in an RNA-seq analysis of gene expression. Four of ten samples were contaminated with theca cells, so that six samples were used in the final analysis (three of each genotype). Of 14 973 genes expressed, 143 were differentially expressed (false discovery rate P < 0.05) in carriers versus noncarriers. Among the positional candidate genes, SMAD6 was 6.6-fold overexpressed in the carriers compared to noncarriers (P < 5 × 10 −5 ). This result was replicated in an independent group of 12 females (7 carriers and 5 noncarriers) using quantitative real-time PCR; SMAD6 was 9.3-fold overexpressed in carriers versus noncarriers (P = 1.17 × 10 −6 ). Association of overexpression of SMAD6, an inhibitor of the BMP/SMAD signaling pathway, with high ovulation rate corresponds well with disabling mutations in ligands (BMP15 and GDF9) and a receptor (BMPR1B) of this pathway that cause increased ovulation rate in sheep.
Introduction
Sheep have been a model species for investigation of genes involved in controlling ovulation rate. For more than a decade, researchers have reported various genetic variants (denoted as Fec for fecundity, until the actual gene has been characterized) that are responsible for variation in ovulation rate and litter size in sheep [1] . Currently, mutations of five genes affecting ovulation rate and litter size in sheep have been characterized at a molecular level. The identified genes are bone morphogenetic protein 15 (BMP15) [2] , growth differentiation factor 9 (GDF9) [3] , bone morphogenetic protein receptor, type 1B (BMPR1B) [4] [5] [6] , beta-1,4-N-acetyl-galactosaminyl transferase 2 (B4GALNT2) [7] , and leptin receptor (LEPR) [8] . Two other genetic variants, FecX2 W [9] and FecD [10] , are known to segregate within families, but the causative polymorphisms remain unknown. There are at least 14 known allelic variants for the five characterized genes that have been identified as associated with hyperprolificacy phenotypes in sheep. Among the identified causative genes for fecundity, BMP15, GDF9, and BMPR1B are involved in the TGF-β signaling pathway [11] . Recently a major gene for ovulation rate has been mapped in cattle to 1.2 Mb region of bovine chromosome 10 [12] . The location of this gene does not correspond to the location of any of the previously characterized major genes for ovulation rate in sheep. Included in the 1.2 Mb candidate region are seven protein-encoding genes, three of which can be considered as positional candidate genes. SMAD family members 3 (SMAD3) and 6 (SMAD6) are components of the transforming growth factor-β (TGFβ)/BMP signaling system [13] , while IQ motif containing H (IQCH) has been associated with menarche in human females [14] . Earlier investigations showed that these candidate genes did not contain any functionally relevant polymorphisms in their coding and 5 and 3 flanking regions [12] , suggesting that the causative polymorphism may be one that alters expression of one of the candidates.
Three of the characterized major genes for ovulation rate in sheep encode either ligands produced by the oocyte (BMP15, GDF9) that bind transmembrane receptors on granulosa cells (GCs), or a transmembrane receptor (BMPR1B). Considering the positional candidate genes, SMAD3 encodes a regulatory Smad (SMAD3) that is phosphorylated in response to ligand-receptor binding. SMAD6 encodes an inhibitory Smad (SMAD6) that blocks either the phosphorylation of regulatory Smads, their binding to common SMAD4 or the binding of regulatory SMAD-SMAD4 complexes to DNA targets in the nucleus. Given that the target cell types for BMP15 and GDF9 binding include GCs, this cell type was chosen as the focus of gene expression analyses in the current study. Gene expression in GCs was compared between animals with one copy of the high ovulation rate allele (carrier) versus those homozygous for the wild-type allele (noncarrier). We hypothesized that a candidate gene within the 1.2 Mb positional candidate region was differentially expressed between carrier and noncarrier. An additional objective was to characterize differences in gene expression beyond the positional candidate region to identify genes that are potentially differentially expressed in response to the effects of the high ovulation rate allele.
Ethics
This research was approved by the University of Wisconsin-Madison College of Agricultural and Life Sciences Animal Care and Use Committee.
Materials and methods

Animal resources
Females used in the following studies were produced by mating (through artificial insemination) bulls that were carriers of the Trio allele with cows that in most cases were of predominantly Angus breeding (noncarriers). Breed composition of the Trio allele carrier bulls was >50% Angus with the remainder of the breed composition being a mix of Hereford, Holstein, and Jersey. Trio allele genotype was inferred by analysis of haplotypes based on three linked markers as described previously [12] . All females were half-sibs and either homozygous wild-type or heterozygous carriers of the Trio allele. Females used in the initial RNA sequencing (RNA-seq) study ranged in age from 18 to 54 month while females used in the subsequent validation quantitative real-time polymerase chain reaction (qRT-PCR) study ranged in age from 27 to 40 month.
Experimental groups and sample collection
GCs used in the first phase of this study were obtained from carrier and noncarrier females, five individuals of each group. The animals were relocated to the Livestock Laboratory on the UW-Madison campus and housed for a week of acclimation prior to the initiation of the study. All animals received a P4 intravaginal controlled internal drug releasing device (CIDR, Eazi-Breed, Zoetis, Florham Park, NJ) on D-8 and this was removed five days later (D-3). Prostaglandin F2α (Estroplan, Parnell, Overland Park, KS) was administered twice 24 h apart on D-3 and D-2. In order to synchronize the emergence of a new follicular wave, animals had ultrasound-guided follicular ablation of all follicles ≥4 mm on D-2, -1, and 0, as previously described [37] . On D-0, after follicle ablation was performed, a new CIDR was inserted and remained in place until D5. The heifers were scanned by ultrasonography once daily to monitor follicle size development. GCs were obtained from presumed dominant follicles on ovaries obtained by unilateral ovariectomy 12 h after CIDR removal. The excised ovary was placed on ice and transported immediately to a laboratory in the adjacent Animal Science building. Ovariectomies were carried out consecutively, with five animals ovariectomized per day for 2 days. A second, independent group of 19 females, ten carriers and nine noncarriers, were managed in a like manner in a subsequent replicate study.
Total ribonucleic acid extraction from granulosa cells
Upon arrival in the laboratory, sample ID and follicle size of all antral follicles ≥5 mm diameter were recorded. Follicle size was measured with a ruler to the nearest half mm in the initial study and to the nearest tenth mm with a digital calipers in the replicate study; follicle diameter was recorded for two measurements made perpendicular to one another and the average calculated. For comparison of follicle size between genotypes, all dominant follicles were utilized with dominance determined by estradiol level as described below. To maximize the yield of GCs, two methods of cell collection were used to acquire cells from both follicular fluid and the follicle's internal wall. Follicular fluid was aspirated using a 1 ml syringe and 20 G needle and discharged into a 2 ml microfuge tube held on ice until dissection was completed. Subsequently, the follicle was dissected and the internal wall swabbed gently with an Isohelix SK2s paddle (Isohelix, Kent, UK). GCs were recovered by spinning the swab paddle in the previously aspirated follicular fluid. The follicular fluid was scanned for the oocyte, using a stereo microscope (model GZ7, Leica Microsystems) and detected oocytes were removed with Downloaded from https://academic.oup.com/biolreprod/article-abstract/98/3/323/4569065 by OUP site access user on 08 October 2018 a Hamilton 10 μl syringe. GCs were collected in a like manner in the replicate study with the substitution of disposable, sterile plastic 10 μl inoculation loops (Globe Scientific, Paramus, NJ) for the Isohelix SK-2 paddles used previously.
Collected samples were centrifuged for 10 min at 300 × g to pellet GCs. The supernatant was collected using a micropipette and transferred to a 1.5 ml microfuge tube and then stored in a -80
• C freezer for later hormonal and proteomic analyses. Total ribonucleic acid (RNA) extraction from GCs was conducted using the Qiagen RNeasy Plus Mini Kit (QIAGEN Inc. Germantown, MD) according to the manufacturer's recommendations. Purified RNA was eluted in 30 μl of RNAse-free water, quantified by spectrometry with a NanoDrop 1000 spectrophotometer (Thermo Scientific, USA), and stored in a -80
• C freezer.
Elimination of genomic deoxyribonucleic acid (DNA)
Upon completion of RNA extractions for a group of animals for the day, the RNA samples were subjected to DNAse treatment to minimize the risk of genomic DNA contamination. The frozen RNA samples were thawed on ice and treated with RNAse-Free DNAse (Qiagen Inc. Germantown, MD) according to the manufacturer's protocol. RNA was combined with 10 μl of buffer RDD, 2.5 μl of DNAse I stock solution (1.8 Kunitz units/μl), and RNase-free water to a final volume of 100 μl. The mixture was incubated on the benchtop at room temperature for 10 min, followed by a column-based RNA cleanup, analogous to that used in the preceding RNA extraction protocol. Finally, RNA quality was checked using an Agilent 2100 Bioanalyzer through the UW-Madison Biotechnology Center.
Prescreening for genomic DNA contamination
Potential genomic DNA contamination of RNA samples was examined using polymerase chain reaction (PCR) and gel electrophoresis. A primer pair previously designed for a PCRrestriction fragment length polymorphism genotyping assay (forward primer: TTTGCTCAGTAGTTGCGCAGTACG; reverse primer: AAATTGAGTTGGGGGCTTCC; amplicon size: 145 bp) was used to test for presence of genomic DNA, as the targeted amplicon is in a nontranscribed region. Briefly, PCR was conducted in 10 μl reactions using RNA samples for the template, and GoTaq DNA polymerase and GoTaq buffer (Promega) per the manufacturer's recommendation. Negative (absent of any RNA and DNA sample) and positive (50 ng of genomic DNA) controls were run concurrently. The PCR products were visualized on a 1.2% electrophoresis gel stained with ethidium bromide.
RNA sequencing
Total RNA samples from GCs of dominant follicles were used for this analysis. Follicles were selected initially based on size. Dominance was evaluated based on estradiol-17β (E 2 ) level using a competitive enzyme-linked immunosorbent assay (ELISA) assay described by Luo et al. [15] , as per the reported increased concentrations of estradiol in follicular fluid of the dominant follicle [16] . Intra-assay and interassay coefficient of variation (CV) were 3.1% and 2.5%. Retrospectively, only follicles with estradiol levels greater than three standard deviations above the assay mean for the combined smallest follicle size class measured (3 mm and 5 mm in carriers and noncarriers, respectively) were considered dominant [17] and used in analyses. The threshold calculated by Garcia-Guerra et al. [17] was based on a different E 2 assay that generated higher values than the current assay. To address this difference, 30 follicular fluid samples were evaluated with both assays to determine the relative difference. The 5.89 fold lower values observed for the current assay were used to adjust the threshold of Garcia-Guerra el al. of 309 ng/ml to a corresponding threshold of 52.5 ng/ml for the current assay. Amount of extracted total RNA from each follicle varied from 1 to 8.5 μg. RNA-seq was conducted at the UW-Madison Biotechnology Center. RNA libraries were generated using the Illumina TruSeq RNA Sample Preparation Kit (Illumina Inc., San Diego, California, USA) per the manufacturer's protocol. Messenger RNA was purified from 1μg of total RNA using poly-T oligo-attached magnetic beads, fragmented using divalent cations under elevated temperature, and purified. Double-stranded complementary DNAs (cDNAs) were synthesized using SuperScript II Reverse Transcriptase (Invitrogen, Carlsbad, California, USA) and random primers, followed by the removal of mRNA using RNAse and purification using Agencourt AMPure XP beads (Qiagen, Valencia, California, USA). DNA fragments were ligated to Illumina adapters and amplified for 9 cycles using Phusion DNA Polymerase and Illumina's PE genomic DNA primer set followed by purification. Quality and quantity of the finished libraries were assessed using an Agilent DNA1000 series chip assay (Agilent Technologies, Santa Clara, CA) and Invitrogen Qubit HS Kit (Invitrogen, Carlsbad, California, USA), respectively. Each library was standardized to a 2 μM concentration. Cluster generation was performed using a TruSeq Single Read Cluster Kit (v4) and the Illumina cBot, with libraries multiplexed for 2 × 100 bp pairedend sequencing using the TruSeq 100 bp SBS kit (v3) and HCS1.6 software, on an Illumina HiSeq2000. All samples were co-loaded on two flow cells. Images were analyzed using CASAVA (Illumina Inc., San Diego, California, USA).
RNA sequencing data analysis
Initial data quality was checked using FastQC (http://www. bioinformatics.babraham.ac.uk/projects/fastqc/). Cutadapt [18] was used to remove the Illumina TruSeq adapters and low-quality sequence from the RNA-seq data. Filtered-and quality-checked reads were mapped to the Bos taurus genome sequence [19] using Tophat [20] and Bowtie, allowing a maximum of a 2 base mismatch. Aligned reads were submitted to Cufflinks [21] for gene annotation using the bovine reference genome Ensembl UMD3.1.79 [22] as the reference. Cufflinks estimates gene expression in fragments per kilobase of gene model per million fragments mapped (FPKM) where reads are normalized with the length of the transcript and the total yield of the machine [23] . Ribosomal RNA and transfer RNA sequence obtained from the UCSC table browser (https://genome.ucsc.edu/cgi-bin/hgTables) were used to ignore expression of those RNAs, with command "-M" in Cufflinks. Assembled transcript output from Cufflinks and reference genome annotation were merged using Cuffmerge to produce a single unified gene transfer format file for use in downstream differential gene expression analysis [23] .
The data were tested in 3 categorical groups: (1) positional candidate genes, (2) a subset of selected genes that are known to be regulated by the SMAD family, and (3) global gene expression analysis. Specifically, seven genes reside in the positional candidate region on chromosome 10 (Bta10:13 591 863-14 790 540 bp) and include SMAD6, SMAD3, alpha-and gamma-adaptin binding protein (AAGAB), IQCH, chromosome 10 open reading frame, human C15orf61 (C10H15orf61), mitogen-activated protein kinase kinase 5 (MAP2K5), and SKI proto-oncogene (SKI) family transcriptional co-repressor 1 (SKOR1). Expression of these genes was tested by t-test with a Bonferroni correction for multiple hypothesis testing and considered significant at a Bonferroni corrected P-value < 0.05 corresponding to a nominal P-value < 0.008. Similarly, FPKM of a subset of genes whose expression is regulated by the BMP signaling pathway was tested using a Bonferroni correction for multiple testing and considered significant at P-value < 0.005. These genes included: inhibitor of DNA binding (ID1, ID2, and ID3), pentraxin 3 (PTX3), GLI family zinc finger (GLI1 and GLI2), retinol binding protein 1 (RBP1), collagen, type XII, alpha 1 (COL12A1), fibulin 1 (FBLN1), nuclear receptor subfamily 5A1 (NR5A1), and transglutaminase 2 (TGM2), [24] [25] [26] [27] [28] [29] [30] . For the comprehensive analysis of all genes, expression was considered significant with at least a 2-fold change (FC) at a P-value ≤ 0.05 and a false discovery rate (FDR) ≤ 0.05 for multiple hypothesis testing [31] . RNA-seq gene expression data for genes uniquely expressed in theca cells including cytochrome P450, family 17, subfamily A, polypeptide 1 (CYP17A1), fibulin 5 (FBLN5), osteoglycin (OGN), and receptor (G protein coupled) activity modifying protein 2 (RAMP2) [32] were used post-hoc to assess degree of contamination of the collected GCs with theca cells. We compared the expression of those genes relative to the luteinizing hormone/choriogonadotropin receptor (LHCGR) and aromatase (CYP17A1) with relative expression levels of >5% were deemed indicative of some theca cell contamination [33] . The data were tested with Barlett's test for homogeneity of variance as recently described by Girard et al. [34] , before and after removal of the suspected contaminated samples.
Gene ontology and pathway analysis
Profiling of several differentially expressed genes for their interactions and networks generates greater biological insight about functions that regulate cellular processes [35, 36] . Genes that are significantly differentially expressed between the carrier and noncarrier group were selected for gene ontology (GO) enrichment analysis of biological processes using GOseq [37] . Lists of differentially and nondifferentially expressed genes (DE and non-DE) were associated with ENSEMBL gene ID using Biomart (http://useast.ensembl.org/biomart/martview/). Biological pathways between those genes were analyzed using the Kyoto Encyclopedia of Genes and Genomes pathway (http://www.kegg.jp/). Collectively, information regarding the interaction of genes and their functions provided an interpretation of distinctive phenotypes between the two groups of animals.
Quantitative real-time PCR, replicate study Total RNA samples from GCs of dominant follicles were used for this analysis. Follicles were selected initially based on size. Dominance was evaluated based on estradiol-17β (E 2 ) level using a competitive ELISA assay as described [17] . One assay was performed and intraassay CV was 4.4%. Where multiple follicles from an individual surpassed the E2 threshold (309 ng/ml), only the follicle with the highest E2 level was used in the analysis providing the extracted RNA surpassed an A260:A280 spectrophotometer reading of 1.7. Amount of extracted total RNA from each follicle varied from 0.17 to 9.43 μg.
Validation of candidate gene results (SMAD6) was carried out using real-time quantitative reverse transcription PCR (qRT-PCR). Reference genes were chosen from among 10 commonly used reference genes [38] based on results of the RNA-seq analysis; specifically, reference genes were chosen for no significant differential expression between genotypes and a level of gene expression that was most comparable with SMAD6. Primers for qRT-PCR were designed using PrimerBLAST at the National Center for Biotechnolgy Information web site (www.ncbi.nlm.nih.gov/tools/primer-blast/) with the following constraints: melting temperature was set at 57
• C -59
• C, guanine and cytosine content of 40%-60%, length 18-22 nucleotides, amplicon length of 100-150 bp, and primer locations in adjacent exons so that amplification from genomic DNA would yield a product greater in length by hundreds to thousands of basepairs and thus unlikely to amplify under the PCR conditions used. Two sets of primers were designed for SMAD6, spanning intron 1 (forward and reverse primers in exons 1 and 2), and intron 2 (forward and reverse primers in exons 2 and 3; Table 1 ). Sequence data for the genes were obtained from GENBANK (www.ncbi.nlm.gov/entrez/query.fcgi). Of the 10 potential reference genes considered, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and peptidylprolyl isomerase A (PPIA) were rejected for differential expression between genotypes in the previous RNA-seq results (nominal P < 0.05). PCR primers designed for actin beta (ACTB), Paf1/RNA polymerase II complex (HRPT1), ribosomal protein L32 (RPL32), and ubiquitin conjugating enzyme E2 D2 (UBE2D2) amplified a similar length fragment from both cDNA and genomic DNA, suggesting the presence of a processed pseudogene in the genome for these four; these were rejected for the possibility of amplification from genomic DNA. PCR primers for TATA-box binding protein (TBP), eukaryotic translation initiation factor 2B subunit beta (EIF2B2), splicing factor 3a subunit 1 (SF3A1), and ring finger protein 20 (RNF20), all produced cDNA-specific amplification of the intended fragment with no amplification of a like-sized fragment from genomic DNA. SF3A1 and RNF20 yielded the strongest amplification from the test cDNA and were selected for use as reference genes. Assays were optimized for similar efficiency between reference and target genes. Potential theca cell contamination was assessed by RT-qPCR comparing expression of genes known to have granulosa and theca cell-specifc gene expression. Follicle stimulating hormone receptor (FSHR) and FBLN5 were used as markers for granulosa and theca cells, respectively [32] .
Complimentary DNA was reverse transcribed from total RNA (200 ng) with the iScript cDNA Synthesis Kit (Bio-RAD) using oligo (dT) and random hexamer primers. The reaction consists of 4 μl iScript reaction mix, 1 μl iScript reverse transcriptase, RNA template, and nuclease-free water to a final volume of 20 μl. The reaction synthesized cDNA with a single cycle for annealing (25 • C), extending c Estradiol concentration (ng/ml) in the follicular fluid. Studies were conducted in two different years and two different estradiol assays were utilized. For the RNA-seq experiment the intra-assay and inter-assay CV were 3.1% and 2.5% and a threshold of ≥52.5 ng/ml was used for dominance. For the second experiment (RT-PCR) all samples were done in a single assay and the intra-assay CV was 4.4%. A threshold of ≥309 ng/ml was used for dominance in the RT-qPCR study. d Not applicable, follicular fluid was not obtainable due to follicle rupture.
RT-qPCR was carried out in a CFX Connect real-time thermal cycler (Bio-Rad Laboratories, Hercules, CA, USA) using the iQ SYBR Green Supermix Kit (Bio-Rad Laboratories, Hercules, CA, USA) according to the manufacturer's protocol. Reactions were carried out in a volume of 20 μl consisting of 10 μl SYBR Select Master Mix (2X), forward and reverse primers (final concentration of 300 nM), and cDNA template brought up to the final volume with RNase-free water. The reactions were initiated with preincubation at 95
• C for 2 min followed by 40 cycles of denaturation at 95
• C for 10 s, and annealing and extension at 60
• C for 10 s. All reactions were run in duplicate. Quantification of FCs for specific genes was determined using the 2 − Ct method [39] . Differences of FC results between the two groups of animals (high and low ovulation rate) were tested with Student t-test comparing normalized threshold cycle (Ct) means between genotypes and were considered significant at a nominal Pvalue < 0.01.
Results
RNA sequencing study
Difference in mean follicle size between genotypes was significant (Pvalue < 0.05) with smaller follicles observed for the carriers (mean of 7.38 ± 0.42 mm, range of 5.5-10 mm) versus noncarriers (mean Table 2 ). Initial data from the RNA-seq analysis totaled 608.5 million reads of which approximately 21% were excluded by the quality check. On average, 96.6% of quality-trimmed reads were mapped with 3% of mapped reads having multiple alignments (Table 3) . Data diagnostics indicated no discrepancies in data distribution between genotypes (Supplementary Figure) . Two animals from each group were found to have contamination of theca cells as indicated by expression of CYP17A1, FBLN5, OGN, and RAMP2 exceeding 5% of the level of LHCGR. Bartlett test for homogeneity of variance, comparing carrier and noncarrier groups, [34] was highly significant (P-value < 0.0001) for CYP17A1, FBLN5, and RAMP2 prior to exclusion of these samples. Two noncarriers (ID: Y026 and Z021) and two carriers (A029 and Y020) were excluded due to theca cell contamination using equalized variance for CYP17A1, FBLN5, OGN, and RAMP2 (P-value < 0.05). Thus, further analysis of this dataset utilized data only from the three animals without theca cell contamination in each group. Data distribution plots produced from the cuffdiff analysis output using cummerbund package (version 2.0.0) [40] indicated no overdispersion of variability in the data of either group (Supplementary Figure) .
Comparison of RNA-seq data between the carrier and noncarrier groups revealed a total of 14 973 genes expressed by both groups. Considering all genes under the criteria of at least a 2-FC in expression and a FDR P-value < 0.05, a total of 143 differentially expressed genes were identified; 84 and 59 genes were upregulated and downregulated in the carrier group, respectively (Table 4 and  Supplementary Tables S1 and S2) . None of the genes hypothesized to be differentially expressed between carrier and noncarrier groups, based on prior knowledge of targets for regulatory SMADs, were differentially expressed, while GO analysis identified 19 functional groups with significant association with expression differences between genotypes (Table 5) .
Among the positional candidate genes, only SMAD6 was differentially expressed (nominal P-value < 5 × 10 −5 , exceeding a Bonferroni corrected threshold of P-value < 0.008). SMAD6 expression was upregulated in the carrier group with a 6.6-fold increase compared to the noncarrier group (Table 5) .
RT-qPCR study
Mean follicle size differed between genotypes (P < 0.01) with smaller mean follicle diameter observed for carriers (mean of 7.67 ± 0.51 mm, range of 3.9-13.2 mm) versus noncarriers (mean of 11.36 ± 1.03 mm, range of 7.8-16.1 mm; Table 2 ). Expression levels for FSHR vs FBLN5 indicated very little contribution of theca cells to the extracted RNA with a 45-fold to greater than 2000-fold expression of FSHR versus FBLN5 observed for individual follicles. After evaluating E2 levels and RNA quality, samples from seven carriers and five noncarriers were used in the final analysis ( Table 2 ). The two alternative SMAD6 amplicons used in the RT-qPCR assays gave highly similar results and the data were combined from the two in theCt analysis of gene expression FC. Carriers exhibited a 9.3-fold increased expression of SMAD6 versus noncarriers (P = 1.17 × 10 −6 ).
Discussion
SMAD6 was differentially expressed and upregulated in Trio carriers. SMAD6 is an inhibitory SMAD in the TGF-β superfamily pathway and preferentially inhibits BMP signaling [41] [42] [43] . SMAD6 is thought to contribute to inhibition through multiple mechanisms. One suggested mechanism is inhibition of formation of the SMAD1-SMAD4 complex by acting as a SMAD4 decoy [42] . A second suggested mechanism is interaction with BMP receptors. SMAD6 has a narrow specificity, with most potent inhibition of type 1 receptors BMPR1A and BMPR1B [44] . By binding to the activated receptor, it could prevent phosphorylation of the regulatory SMADs [45] . Furthermore, SMAD6 promotes ubiquitination and degradation of several type 1 receptors and activated R-Smads, by engaging SMAD ubiquitin regulatory factor 1 (Smurf1) cooperatively, to inhibit BMP signaling [46] . In mouse GCs, BMPR1A and BMPR1B work together as ovarian tumorigenesis suppressors [47] . Both of the BMP receptors are preferentially bound by BMP2 and BMP4 [48] , while BMP15 preferentially binds to BMPR1B [49] . BMP6 and BMP7 have higher affinity binding to ACVR1 compared to BMPR1A and BMPR1B [50, 51] . Sheep have proven a useful model to elucidate genetics of ovulation rate and prolificacy. The study of fecundity genes in sheep has led to the identification of the role of the BMP system in folliculogenesis, where a decrease in BMP signaling causes an increase in ovulation rate. High expression of SMAD6 in the GCs of carriers suggests involvement of the BMP signaling system in the high ovulation rate observed in the cattle family studied here. The inhibitory function of SMAD6 on the BMP signaling pathway mimics the loss of function observed for high ovulation rate mutations in BMPR1B, BMP15, and GDF9 [52, 53] that result in decreased BMP signaling. In sheep, mutations that cause complete or partial loss of function of the BMPs result in decreased GC numbers due to impaired cellular proliferation, acquisition of Luteinizing hormone (LH) responsiveness at a smaller size, and potentially increased Follicle-stimulating Downloaded from https://academic.oup.com/biolreprod/article-abstract/98/3/323/4569065 by OUP site access user on 08 October 2018 3.4 Bos taurus brain-specific angiogenesis inhibitor 1 (BAI1) 3.1 Fructose-bisphosphatase 1 (FBP1) 3 a FDR P-value < 0.005 in all cases. b complete listing of all differentially expressed genes with FC > 2 and false discovery P < 0.05 can be found in Supplementary Tables 1 and 2. hormone (FSH) sensitivity due to decreased BMP inhibition of the FSH pathway [53] [54] [55] .
In the current study, GCs were used to reveal gene expression differences that contribute to endocrine or paracrine influences leading to the selection of one versus multiple follicles for ovulation. GCs are responsible for producing inhibin during early follicle development and estradiol later at the preovulatory stage [56] that have negative effects on the release of FSH from the anterior pituitary. In addition, they are also the target for TGFβ superfamily members (BMP15 and GDF9) previously associated with an elevated ovulation rate in sheep [2, 3] . Oocytes are the primary source of BMP15 and GDF9, across a wide range of mammalian species [57] . BMP15 is a potent mitogen for GCs and is involved in the regulation of steroidogenesis [58, 59] . There is evidence of smaller follicles and fewer GCs in sheep with mutant fecundity genes, due to lack of stimulation for proliferation by the BMPs [55] . Hypothetically, higher expression of SMAD6 in the carrier group is likely to impair the BMP signaling pathway resulting in fewer GCs and the observed smaller follicles in carriers compared to noncarriers.
Heterozygous ewes with the BMP15 mutations display multiple pre-ovulatory follicles, with smaller size and fewer GCs compared to the wild-type [60] . Collectively, those smaller follicles with fewer GCs produce a total amount of estradiol and inhibin that is comparable to the wild-type [55, 60] . In addition, BMP15 was proposed to inhibit FSH receptor gene expression in rat GCs [61] ; however, species differences may exist as shown by a study in ewes heterozygous for both the Booroola (BMPR1B) and Inverdale (BMP15) mutations where no difference in FSHR mRNA was observed [62] . Conversely, in ewes with BMPR1B and BMP15 mutations, earlier onset of LH responsiveness was proposed to enable survival of smaller follicles during suppression of gonadotropins [55] leading to development of multiple healthy follicles and an increase in ovulation rate. Interruption of BMP15 signaling by SMAD6 might enhance the expression of LH receptors at a smaller follicle size allowing follicles to continue to grow despite the declining concentrations of FSH. Ovarian follicle development consists of several phases prior to ovulation. Follicular dynamics involve four processes that are termed recruitment, selection, dominance, and atresia [63] . During each of these processes, the follicles change morphologically and physiologically due to responses to endocrine and paracrine stimuli. All of the processes are accompanied by distinct maturational changes in hormonal production and expression of receptors on GCs. Recently, Hatzirodos et al. [64] identified differences in gene expression during two stages of follicular development, recruitment and dominance, by using gene expression arrays of GCs from small versus large antral follicles. Most of the genes identified in this previous study were not significantly differentially expressed in the current study. Specifically, six out of 354 and three out of 95 up-and downregulated genes, respectively, identified by Hatzirodos et al. [64] were differentially expressed in the current study (Table 7) . This result is not unexpected, given that follicles in the same stage of development were compared in the current study versus Hatzirodos et al. [64] where the comparison was between different stages of follicular development. SMAD6 has been reported to inhibit BMP signaling through SMADs1/5/8, consequently differential gene expression observed in response to knockouts of SMADs1/5 in mice would be expected to potentially suggest genes that are differentially expressed in the current study given the overexpression of SMAD6. Of eight genes differentially expressed in dKo SMAD1/5 mice [29] , only transforming growth factor, beta induced (TGFBI) was differentially expressed in the current study. TGFBI was significantly upregulated in SMAD1 and SMAD5 dKO tumor mice and in the carrier group in the current study (FC = 3.05).
Work with mouse granulosa tumor cells has identified SMADs1/5 as regulators of platelet-derived growth factors alpha (PDGFA) gene expression with the knockdown of SMADs1/5 leading to upregulation of PDGFA [65] . Similarly, in the current study, expression of PDGF1 was upregulated in the carrier group (FC = 2.25; Supplementary Table S2 ). Members of the PDGF family have a vital role in developmental processes such as proliferation, angiogenesis, and apoptosis, as well as in human diseases and cancer [66, 67] . PDGFs primarily act as paracrine growth factors with dynamic physiological changes in expression of both the proteins and their receptors [66] . Absence of SMADs1/5 in dKo mouse granulosa tumor cells was thought to reduce competition with transcription factor SP1 for the promoter binding site [65] . In the current study, both SMAD1 and SMAD5 were not differentially expressed between the groups; however, bioavailability or activation of SMAD1 and SMAD5 was not evaluated in our study. Consistent with the findings of Tripurani et al. [65] , other key proliferation and angiogenic factors, i.e. PDGFB, vascular endothelial growth factor (VEGFA and VEGFB), and SP1, the transcription activator for PDGFA, were not differentially expressed in the current study. Several mechanisms for the inhibitory effect of SMAD6 have been reported including inducing ubiquitination and degradation via formation of complexes with SMURF1 [46] and interference with the signaling pathway by formation of complexes with R-SMADs [42] . Both would result in the reduction of availability of R-SMADs. This might be a possible cause for the elevated expression of PDGFA in the carrier group.
Vanin 1 (VNN1) is a gene with a known role in folliculogenesis that was highly expressed in the GCs of carriers compared to noncarriers (FC = 3.77). VNN1 is a surface molecule with pantetheinase activity and plays an important role in the oxidative stress response in oocytes [68, 69] . This gene has been linked to follicular atresia and exhibits a linear increase in successive stages of follicular developmental i.e. growing, plateau, and atresia [34] . Higher expression of VNN1 might suggest a role to protect the whole follicle in response to follicle oxidative state [69] . Theoretically, elevation of protective genes in the GCs might enable longer survival for GCs and the follicle. Expression of other marker genes for follicular atresia [34] did not differ between genotypes in the current analysis.
Proliferating GCs need iron, transported by transferrin (TF), which is a central player in transportation and circulation of iron to many tissues [70, 71] . Transferrin is primarily synthesized in the liver and there is evidence of its de novo production in human Sertoli and GCs [72] . Transferrin has been reported to inhibit FSH-stimulated aromatase activity, causing lower production of estradiol in rat [73] and pig [74] GCs in vivo, albeit with species differences in dose effects. It has been hypothesized that follicular fluid transferrin might be related to proliferation and maturation of GCs [75] . Transferrin might hold a significant regulatory role in the ovary. However, the cutoff concentration of transferrin in different physiological and biological systems is still not clear. In our analysis, the carrier group exhibited downregulated expression (FC = 0.11) of transferrin, compared to the noncarrier. Similarly, the feline leukemia virus subgroup C cellular receptor family, member 2 (FLVCR2) gene is downregulated in the carrier group (FC = 0.23). FLVCR2 is an importer of heme [76] , a ferrous ion that is involved in various biological processes including oxygen transport, modulation of gene expression, and cell proliferation (reviewed by Chiabrando et al. [77] ). Given the requirement of transferrin and FLVCR2 for proliferative cells, lower expression of these genes might decrease GC proliferation. Lesser proliferation of GCs due to inhibition of the BMP signaling pathway has been previously associated with higher ovulation rate in sheep [53] [54] [55] .
In our analysis, hemoglobin beta (HBB) is among the highest upregulated genes in the noncarrier group (FC = 7.4). Hemoglobin consists of a dimer of α-and β-globins, and their main function is to transport oxygen along with other gasses such as carbon dioxide, carbon monoxide, and nitric oxide [78] . The avascular environment of ovarian follicles has raised questions on how oocytes in large antral follicles develop in the expected low-oxygen environment. Microarray analysis of cumulus-oocyte complexes and GCs in human and mouse revealed the expression of hemoglobin alpha (HBA1) and HBB [79, 80] . Erythrocytes are not the sole producer of hemoglobin; however, the reason why hemoglobin is expressed in the antral follicle is still not clear. There are several theories about the expression of hemoglobin in the follicle, including increased expression in response to a low-oxygen environment [81] or increased expression due to sensitivity of the oocyte towards hypoxia within the follicle [82] , resulting from an oxygen gradient due to GCs density and follicle size [80] . The greater follicle size for noncarriers versus carriers is consistent with previous observations [83] , and theoretically might suggest lower oxygen levels in the larger noncarrier follicles. Oxygen tension in follicular fluid is lower as follicle development progresses toward maturation and the periovulatory stage [84] . The noncarriers might also be at a slightly more advanced stage of development towards ovulation compared to the carriers, or correspondingly, it might suggest that follicles from carriers develop at a slower rate.
In conclusion, we have identified a positional candidate gene (SMAD6) that is overexpressed in the GCs of carrier females in comparison with noncarriers. The important inhibitory role of this gene in the BMP signaling pathway suggests interference with the pathway akin to effects of previously identified mutations in BMP signaling pathway ligands (BMP15, GDF9) and receptor (BMPR1B) that cause higher ovulation rate. Further studies of animals with this altered SMAD6 allele are needed to elucidate the mechanism by which ovulation rate is increased.
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